REGISTRATION NO LONGER POSSIBLE DUE TO REACHING MAXIMUM NUMBER OF PARTICIPANTS

Advanced technologies are increasingly used in the treatment of patients. New innovative technologies that come about through the cooperation of physicians with physicists and engineers. For instance, radioactive isotopes are developed that are widely used for diagnostics but also for therapeutic applications. The Netherlands plays a leading role in the development of treatment methods and the radioactive substances needed for them. Patients expect the availability of these substances at all times when they need them. Few realise what is necessary to have these substances available and how vulnerable the supply-chain is worldwide.

This symposium will provide an overview of developments in Nuclear Medicine from the medical as well as physical, political and financial perspectives. Insight will be given into how efforts are being made to ensure the availability of radioactive isotopes for future generations as well.

The following speakers will give a talk:

- Dr Marcel Stokkel - chairman Dutch Society for Nuclear Medicine:

Nuclear Medicine: status and development

- Dr Ir. Ronald Schram - director of strategic alliances NRG:

Production and development of medical isotopes

- Dr Mark Konijnenberg - clinical physicist at the Nuclear Medicine department of Erasmus MC Rotterdam

Therapeutic radionuclides: from laboratory to patient

- Dr Hermen van der Lugt - director PALLAS:

PALLAS: guaranteeing the availability of medical isotopes

Dr.Heleen Miedema, director Health studies UT, will chair the symposium this afternoon.

Afterwards, there will be an opportunity to talk afterwards over a drink.

This symposium has been organised in cooperation with Netherlands Nuclear Society, Technical Medicine (University of Twente) and Study Association Paradoks.